These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37622528)

  • 21. Triple Canal Occlusion for the Treatment of Intractable Menière's Disease.
    Gill C; Muzaffar J; Kumar R; Irving R
    Otol Neurotol; 2021 Jan; 42(1):116-120. PubMed ID: 33201079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM
    Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifestyle and dietary interventions for Ménière's disease.
    Webster KE; George B; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Murdin L; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015244. PubMed ID: 36848645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine.
    Sbeih F; Christov F; Gluth MB
    Ann Otol Rhinol Laryngol; 2018 May; 127(5):331-337. PubMed ID: 29546771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the surgical treatment of Ménière's diseases.
    Ghossaini SN; Wazen JJ
    J Am Acad Audiol; 2006 Jan; 17(1):38-44. PubMed ID: 16640059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.
    Ward B; Wettstein V; Golding J; Corallo G; Nuti D; Trabalzini F; Mandala M
    J Int Adv Otol; 2019 Apr; 15(1):112-117. PubMed ID: 31058600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research.
    Iwasaki S; Shojaku H; Murofushi T; Seo T; Kitahara T; Origasa H; Watanabe Y; Suzuki M; Takeda N;
    Auris Nasus Larynx; 2021 Feb; 48(1):15-22. PubMed ID: 33131962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH; Gamst AC; Anderson JP; Harris JP
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of unilateral Ménière's disease and clinical evolutionary models.
    Pérez-Carbonell T; Orts-Alborch M; Pérez-Guillén V; Tenías-Burillo JM; Pla-Gil I; Marco-Algarra J; Pérez-Garrigues H
    J Laryngol Otol; 2023 Jun; 137(6):629-636. PubMed ID: 35924453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The principal component analysis of clinical symptoms in patients with Meniere's disease during acute phase].
    Xiong B; Liang Y; Zhao X; Liu J; Lin C; Lin L; Zeng X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Apr; 29(8):736-9. PubMed ID: 26248450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
    Devaiah AK; Ator GA
    Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière's disease.
    Söderman AC; Bergenius J; Bagger-Sjöbäck D; Tjell C; Langius A
    Otol Neurotol; 2001 Jul; 22(4):526-33. PubMed ID: 11449112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
    Okuda H; Aoki M; Ogawa B; Shibata H; Ueda N; Ohashi T; Hayashi H; Nishihori T; Kuze B; Ogawa T
    Am J Otolaryngol; 2021; 42(6):103141. PubMed ID: 34171697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Middle ear gentamicin-soaked pledgets in the treatment of Ménière's disease.
    MacKeith SA; Whiteside OJ; Mawby T; Bottrill ID
    Otol Neurotol; 2014 Feb; 35(2):305-9. PubMed ID: 24448291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.